SynthesisFrontiers in immunology2025

Efficacy and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a meta-analysis with trial sequential analysis of randomized controlled trials.

Ji Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.